How can CT complement angiography and intravascular imaging in PCI? Drs. Sandoval and Escaned discuss CT-guided PCI, from preprocedural planning to intraprocedural guidance.
Watch: https://t.co/HZV0NUzwyZ
#cardiotwitter#CCTA#TCT2026
Lifetime management is not only a structural heart concept. Igor Gosev, MD, PhD, discusses how HeartMate 3 LVAD therapy and earlier advanced HF referral can preserve future treatment options beyond the next procedure.
https://t.co/PY3mPi99eM #cardiotwitter
How can CT complement angiography and intravascular imaging in PCI? Drs. Sandoval and Escaned discuss CT-guided PCI, from preprocedural planning to intraprocedural guidance.
Watch: https://t.co/BTBvBiAUVq
#cardiotwitter#CCTA#TCT2026
From Oklahoma City to rural communities, Jim Melton, DO, and Marcus Smith, MD, discuss expanding cardiovascular care beyond the hospital through a hybrid OBL/ASC model, with a focus on access, patient selection, same-day care, and the patient experience.
https://t.co/7MfYPuTvuq
Plan your TCT 2026 LBCT schedule! Review CLD's 5-minute overview of selected trials, with clinical context, key endpoints, and presentation times to help you prioritize the results you don't want to miss.
https://t.co/6RMyi30Vqm #cardiotwitter@invasivecardiol
Did you continue — or stop — working invasively in the cath lab during pregnancy? An international study from Hannover Heart Rhythm Center is seeking women to share their experiences in a 15-question survey.
https://t.co/Xxl18qgwkD
#cardiotwitter
How should coronary calcium influence plaque modification during PCI? Jake Rogers and Richard Merschen review IVUS/OCT assessment, atherectomy, IVL, and specialty balloons, with 10 tips for managing calcified lesions.
https://t.co/3620fCiOxA #cardiotwitter@invasivecardiol
Brian K. Jefferson, MD, reviews complex recurrent ISR treated w/ the AGENT™ DCB. An AGENT-treated segment remained patent >3 yrs, while a separate adjacent segment treated w/ POBA 13 mos later restenosed within 6 mos.
https://t.co/k0RYKJwnPd
Procedural choices today can affect tomorrow’s HF options. Igor Gosev, MD, PhD, discusses sternum-preserving HeartMate 3 LVAD implantation and how it may fit into a lifetime advanced HF treatment strategy.
https://t.co/XdUGUSSNVT #cardiotwitter
Every cardiology subspecialty reached record median compensation in MedAxiom’s 2026 survey. Overall median cardiology compensation rose nearly 5% to $727,712, while cardiac surgery surpassed $1 million for the first time.
https://t.co/zPSWtS89cJ #cardiotwitter
When should an interventional cardiologist think beyond the next coronary procedure? Igor Gosev, MD, PhD, discusses earlier advanced HF referral and HeartMate 3 LVAD therapy as part of a lifetime treatment strategy.
https://t.co/SFMMsmdAnX #cardiotwitter
Creating a New Path for Long, Heavily Calcified Femoropopliteal Occlusions With DETOUR
Drs Zakir and Usman discuss using the DETOUR™ System earlier to bypass complex femoropopliteal occlusions.
https://t.co/5OeiBFqshp
Did you continue — or stop — working invasively in the cath lab during pregnancy? An international study from Hannover Heart Rhythm Center is seeking women to share their experiences in a 15-question survey.
https://t.co/lJSAazhkk0
#cardiotwitter
Kevin Nicholas, MSN, RN, CV-BC, shares how Miami Cardiac and Vascular Institute is expanding cardiovascular care into ASCs, from staffing and workflow to Philips technology and plans for new sites across South Florida.
https://t.co/RgOgTCqXfx
A comprehensive #hypertension program goes beyond any single therapy. Drs. Maria Carolina Delgado-Lelievre and Iliana Hurtado-Rendón discuss individualized evaluation, multidisciplinary care, renal denervation, and long-term follow-up.
https://t.co/KW8YzSNmv1 #cardiotwitter#RDN
What happens when a STEMI arrives and the cath lab call team is already committed elsewhere? Kimberly Perdue, MBA, RT(R), makes the case for a protected four-person model to preserve essential functions and dependable STEMI readiness.
https://t.co/xaltFRU6oM #cardiotwitter#STEMI
Rushi Parikh, MD, presents an NSTEMI case using Makoto HD NIRS-IVUS (Nipro Medical) to guide stent sizing and landing zones, and identify extensive lipid-rich plaque that helped inform post-PCI lipid-lowering therapy.
https://t.co/n9Q8WnDQ8Y
From PERT activation to mechanical thrombectomy and long-term follow-up, PE care is evolving. Pratik Sandesara, MD, discusses STORM-PE and Penumbra’s Lightning Flash® CAVT™ technology.
https://t.co/oooBL1uje6
When a cath lab crisis hits, what should happen first? @MortonKern outlines practical steps for managing no-reflow, coronary perforation, acute vessel closure, & vascular access complications + who to call & communication under pressure. https://t.co/TqKejI9ZcJ #cardiotwitter
Why do some ASC startups fall short of expectations? Strategic planning, realistic market and volume assumptions, physician alignment, and operational readiness can make the difference.
https://t.co/BQpcwBO0bA